Cognitive and Motor Tasks in Cerebral Palsy

April 15, 2021 updated by: mbudak, Istanbul Medipol University Hospital

Effect of Cognitive and Motor Tasks on Gait in Individuals With Cerebral Palsy

Various gait deviations are observed in children with cerebral palsy. Our aim was to determine the effect of cognitive task (CT) and motor task (MT) on gait in children with cerebral palsy (CP). 15 children with CP, between 9-15 years old, with Communication Function Classification System (CFSS) level I, with Gross Motor Function Classification System (GMFCS) and Manual Ability Classification System (MACS) level I-II were included in the study. The gait with four different conditions (single gait, CT, MT and CT&MT) was evaluated by Kinovea video analysis method on a 10-meter course.

Results:

Study Overview

Detailed Description

All children with CP were instructed to walk on the track under four different conditions:

  • Single: Walking without task at a self-selected speed
  • Cognitive Task (CT): Walking while counting down rhythmically from 20 in threes
  • Motor Task (MT): Walking while carrying an empty box
  • CT + MT: Walking while carrying an empty box and counting down rhythmically from 20 in threes

The task was explained to individuals by a physiotherapist. The individuals were not allowed to use orthosis during walking performance. Running was not accepted. 30 seconds were given to take a break between tasks. The physiotherapist followed the individuals along the track in case of any falling. If the child was not able to complete the track (falling or need to rest), the evaluation was accepted uncomplete and was excluded from the database.

The Kinovea-08.15 software program was used to assess all of the outputs (images and videos) from the camera

Study Type

Observational

Enrollment (Actual)

15

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beykoz
      • Istanbul, Beykoz, Turkey, 34815
        • Istanbul Medipol University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 15 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

15 children with Cerebral Palsy, between 9-15 years old

Description

Inclusion Criteria:

  • having been diagnosed with CP in the health committee
  • being between 9-15 years of age, having a mental level as "normal" (in terms of compliance with the exercises)
  • being in Gross Motor Function Classification System (GMFSC) Level I-II
  • being in Manual Ability Classification System (MACS) Level I-II
  • being in Communication Function Classification System (CFSS) Level I (communication method is speech).

Exclusion Criteria:

  • having a mental retardation
  • having severe vision impairment
  • underwenting Botulinum Toxin (BOTOX) injection or surgery affecting lower extremities in the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Children with hemiparetic Cerebral palsy
15 children with CP, between 9-15 years old

The gait with four different conditions (single gait, Cognitive Task, Motor Task and Cognitive Task&Motor Task) was evaluated by Kinovea video analysis method on a 10-meter course.

  • Single: Walking without task at a self-selected speed
  • Cognitive Task (CT): Walking while counting down rhythmically from 20 in threes
  • Motor Task (MT): Walking while carrying an empty box
  • CT + MT: Walking while carrying an empty box and counting down rhythmically from 20 in threes

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
2D Gait analysis
Time Frame: through study completion, an average of 1 year
Kinovea video analysis
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 1, 2018

Primary Completion (ACTUAL)

May 1, 2019

Study Completion (ACTUAL)

July 1, 2019

Study Registration Dates

First Submitted

April 14, 2021

First Submitted That Met QC Criteria

April 15, 2021

First Posted (ACTUAL)

April 20, 2021

Study Record Updates

Last Update Posted (ACTUAL)

April 20, 2021

Last Update Submitted That Met QC Criteria

April 15, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Palsy

Clinical Trials on 2D Gait analysis

Subscribe